Featured in Chronic Spontaneous Urticaria (CSU)
Early Response, Sustained Control: 52-Week Outcomes With Remibrutinib
Discover this week's featured video and expert opinion
Latest Chronic Spontaneous Urticaria (CSU) Videos
Chronic Spontaneous Urticaria (CSU)
Advances and Applications in Chronic Spontaneous Urticaria Care
Featuring Naiem Issa, MD, PhD, FAAD | Dawn Merritt, DO
Chronic Spontaneous Urticaria (CSU)
CME Satellite Symposium: Tips and Tricks to Advancing Chronic Spontaneous Urticaria Care
Featuring Marc Serota, MD | Michelle Tarbox, MD
Featured CME on Chronic Spontaneous Urticaria (CSU)
Chronic Spontaneous Urticaria (CSU) Episodes to Explore
Episode 119
Chronic Hives Are Back! New Perspectives on Evaluation and Management
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, sits down with Jason Hawkes, MD, Chief Scientific Officer...
Episode 78
Improving Your Clinical Approach To Chronic Urticaria
In this episode of Derms and Conditions, host James Q Del Rosso, DO, engages in a comprehensive discussion with Jason Hawkes, MD,...
Chronic Spontaneous Urticaria (CSU) News & Research
Pooled Phase 3 Data From CSU Trials
Sponsored by Novartis Medical Affairs | December 1, 2025
LIMITATIONS: Post hoc or prespecified exploratory analyses were performed in the poster above and results...
CSU Disease Activity Data From a Phase 3 Trial
Sponsored by Novartis Medical Affairs | December 1, 2025
LIMITATIONS: Post hoc or prespecified exploratory analyses were performed in the poster above and results...
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions